First -Line Defense Mechanisms in the Peritoneal Cavity during Peritoneal Dialysis

Verbrugh H.A. Organisms causing peritonitis. Contrib Nephrol 1990; 85: 39–48.

Verbrugh H.A. , van Bronswijk H. , Oe P.L. , Verhoef J. The fate of phagocytized Staphylococcus epidermidis. Survival and growth in human mononuclear phagocytes as a potential pathogenic mechanism. Zentralbl Bakteriol Hyg [A] 1987; 16: (Suppl) 55–65.

Ruiz P. , Gomez F. , Schreiber A.D. Impaired function of macrophage Fc receptors in end-stage renal disease. N Engl J Med 1990; 322: 717–22.

Vanholder R. , Dell'Aquila R. , Jacobs V. Depressed phagocytosis in hemodialyzed patients: in vivo and in vitro mechanisms. Nephron 1993; 63: 409–15.

Fijen J.W. , Struijk D.G. , Krediet R.T. , Boeschoten E.W. , de Vries J.P. , Arisz L. Dialysate leukocytosis in CAPD patients without clinical infection. Neth J Med 1988; 33: 270–80.

Van Bronswijk H. Microbial invasion and peritoneal defence in CAPD patients (Doctoral thesis). Amsterdam: Medical Faculty, Free University, 1988.

Steinberg B. In: Infections of the peritoneum. New York: Paul Hoeber, 1944: 1–455.

Dunn D.L. , Barke R.A. , Ewald D.C. , Simmons R.L. Macrophages and translymphatic absorption represent the first line of host defence of the peritoneal cavity. Arch Surg 1987; 122: 105–10.

Glancey G.R. , Cameron J.S. , Ogg C.S. Peritoneal drainage: an important element in host defence against staphylococcal peritonitis in patients on CAPD. Nephrol Dial Transplant 1992; 7: 627–31.

Dunn D.L. , Barke R.A. , Ahrenholz D.H. , Humphrey E.W. , Simmons R.L. The adjuvant effect of peritoneal fluid in experimental peritonitis; mechanism and clinical implications. Ann Surg 1984; 20: 37–43.

Simberkoff M.S. , Moldover N.H. , Weiss G. Bactericidal and opsonic activity of cirrhotic ascites and non-ascitic peritoneal fluid. J Lab Clin Med 1978; 91: 831–9.

Verhoef J. , Peterson P.K. , Sabalt L.D. , Quie P.G. Opsonic requirements for staphylococcal phagocytosis: heterogenicity among strains. Immunology 1977; 33: 191–7.

Bennett-Jones D.N. , Yewdall V.M.A. , Gillespie C.M.E. , Ogg CS , Cameron J.S. Strain differences in opsonization of Staphylococcus epidermidis. Perit Dial Int 1989; 9: 333–9.

Van Bronswijk H. , Verbrugh H.A. , Heezius HCJM Heterogeneity in opsonic requirements of Staphylococcus epidermidis: the relative importance of surface hydrophobicity, capsules and slime. Immunology 1989; 67: 81–6.

Verbrugh H.A. , Peterson P.K. , Nguyen B.Y.T. , Sisson S.P. , Kim Y. Opsonization of encapsulated staphylococci: the role of specific antibody and complement. J Immunol 1982; 129: 1681–6.

Verbrugh H.A. , Keane W.F. , Hoidal J.R. , Freiberg M.R. , Elliott G.R. , Peterson P.K. Peritoneal macrophages and opsonins: antibacterial defense in patients undergoing chronic peritoneal dialysis. J Infect Dis 1983; 147: 1018–29.

Keane W.F. , Comty C.M. , Verbrugh H.A. , Peterson P.K. Opsonic deficiency of peritoneal dialysis effluent in continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25: 539–43.

Clark L.A. , Easmon C.S.F. Opsonic requirements of Staphylococcus epidermidis. J Med Microbiol 1986; 22: 1–7.

McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B.J.R. Relationship of IgG, C3 and transferrin with opsonising and bacteriostatic activity of peritoneal fluid from CAPD patients and the incidence of peritonitis. Nephrol Dial Transplant 1987; 2: 551–6.

De Fijter C.W.H. , Verbrugh H.A. , Oe P.L. Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis. Kidney Int 1992; 42: 947–50.

Lamperi S. , Carozzi S. Defective opsonic activity of peritoneal effluent during continuous ambulatory peritoneal dialysis (CAPD): importance and prevention. Perit Dial Bull 1986; 6: 87–92.

Zemel D. , Struijk D.G. , Krediet R.T. No relationship between dialysate IgG and peritonitis incidence. Proceedings of the 6th Benelux Dialysis Symposium, Amsterdam, 1989: 61–6.

Coles G.A. , Alobaidi H.M. , Topley N. , Davies M. Opsonic activity of dialysis effluent predicts those at risk of Staphylococcus epidermidis. Nephrol Dial Transplant 1987; 2: 359–65.

Van Bronswijk H. , Van der Meulen J. , Nauta J.J.P. , Verbrugh H.A. , Oe P.L. , Verhoef J. Peritonitis in continuous ambulatory peritoneal dialysis: poor training or failing host defences. In: van Bronswijk H. Microbial invasion and peritoneal defence in CAPD patients (Medical thesis). Amsterdam: Medical Faculty, Free University, 1988: 33–48.

Brulez H.F.H. , Ter Wee P.M. , Verbeelen D. , Dekker H.A.T. , Verbrugh H.A. Biocompatibility of a 1.1% amino acids (AA) containing dialysis fluid (PDF) in peritoneal dialysis patients. J Am Soc Nephrol 1994; 5: 488.

Takada Y. , Arimoto Y.Y. , Mineda H. , Takada A. Inhibition of the classical and alternative pathways by amino acids and their derivatives. Immunology 1978; 34: 509–15.

Takada A. , Shirahama S. , Takada Y. Inhibition of the activation of the first component of complement, C 1, by various amino acids or peptides. Immunopharmacology 1984; 8: 27–35.

Goldstein C.S. , Bomalski J.S. , Zurier R.B. , Nelson E.G. , Douglas S.D. Analysis of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Kidney Int 1984; 26: 733–40.

Peterson P.K. , Gaziano E. , Suh H.J. , Devalon M. , Peterson L. , Keane W.F. Antimicrobial activities of dialysateelicited and resident human peritoneal macrophages. Infect Immun 1985; 49: 212–18.

Suassuna J.H.R. , Das Neves F.C. , Hartley R.B. , Ogg C.S. , Cameron J.S. Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 1994; 46: 443–54.

Muijsken M.A. , Heezius HJCM , Verhoef J. , Verbrugh H.A. Role of mesothelial cells in peritoneal antibacterial defense. J Clin Pathol 1991; 44: 600–4.

Verbrugh H.A. , Keane W.F. , Conroy M.E. , Peterson P.K. Bacterial growth and killing in continuous ambulatory peritoneal dialysis fluids. J Clin Microbiol 1984; 20: 199–203.

Brulez H.F.H. , Heezius HCJM , de Fijter C.W.J. , Oe P.L. , Verhoef J. , Verbrugh H.A. In vitro compatibility of a 1.1% amino acid containing peritoneal dialysis fluid with phagocyte function. In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1994; 10: 241–4.

Alobaidi H.M. , Coles G.A. , Davies M. , Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function Nephrol Dial Transplant 1986; 1: 16–21.

van Bronswijk H. , Verbrugh H.A. , Heezius HCJM , van der Meulen J. , Oe P.L. , Verhoef J. Dialysate fluids and local host resistance in patients on continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1988; 7: 368–73.

Davies S.J. Peritoneal lymphocyte populations in CAPD patients. Contrib Nephrol 1990; 85: 16–23.

Cichoki T. , Hanicki Z. , Sulowics W. , Smolenski O. , Kopec J. , Zembala M. Output of peritoneal cells into peritoneal dialysate. Cytochemical and functional studies. Nephron 1983; 33: 175–82.

Bos H.J. , van Bronswijk H. , Helmerhorst T J.M. , Oe P.L. , Hoefsmit E.C.M. , Beelen R.H.J. Distinct sub populations of elicited human macrophages in peritoneal dialysis patients and women undergoing laparascopy: a study on peroxidatic activity. J Leukocyte Biol 1988; 43: 172–8.

MacGowan A.P. , Peterson P.K. , Keane W. , Quie P.G. Human peritoneal macrophage phagocytic, killing and chemiluminescent responses to opsonised Listeria monocytogenes. Infect Immun 1983; 40: 440–3.

Betjes M.G.H. , Tuk C.W. , Krediet R.T. , Arisz L. , Beelen R.H.J. Antigen-presenting capacity of macrophages and dendritic cells in the peritoneal cavity of patients treated with peritoneal dialysis. Clin Exp Immunol 1993; 94: 377–84.

Betjes M.G.H. , Tuk C.W. , Struijk D.G. Immunoeffector characteristics of peritoneal cells during CAPD treatment: a longitudinal study. Kidney Int 1993; 43: 641–8.

Chandrasekaran B. , Schultz E.F. , Debari V. A. , Ronquillo C.T. , Needle M.A. , Surface marker characterization of peritoneal dialysis patients’ intraperitoneal leukocytes by monoclonal antibodies. In: Maher J.F. , Winchester J.F. , eds. Frontiers in peritoneal dialysis. New York: Field & Rich, 1986: 583–5.

Lewis S.L. , Norris P.J. , Holmes C. Phenotypic characterization of monocytes and macrophages from CAPD patients. Trans Am Soc Artif Intern Organs 1990; 36: M575–7.

Gbarah A. , Gahmberg C.G. , Boner G. , Sharon N. The leukocyte surface antigens CD11b and CD18 mediate the oxidative burst activation of human peritoneal macrophages induced by type 1 fimbriated Escheria coli. J Leukocyte Biol 1993; 54: 111–13.

Davies S.J. , Suassuna J. , Ogg C.S. , Cameron J.S. Activation of immunocompetent cells in the peritoneum of patients treated with CAPD. Kidney Int 1989; 36: 661–8.

Bos H.J. , Meyer F. , de Veld J.C. , Beelen R.H.J. Peritoneal dialysis fluid induces change of mononuclear phagocyte proportions. Kidney Int 1989; 36: 20–6.

McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B.J.R. Release of hydrogen peroxide and expression of HLA-DR and transferrin receptors by monocytes and peritoneal macrophages from patients undergoing continuous ambulatory peritoneal dialysis and normal controls. Clin Immunol Immunopathol 1990; 56: 151–8.

Moughal N.A. , McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B.J.R. Expression of transferrin receptors by monocytes and peritoneal macrophages from renal failure patients treated by continuous ambulatory peritoneal dialysis (CAPD). Eur J Clin Invest 1991; 21: 592–6.

Lewis S. , Norris P.J. Monocyte/macrophage function in CAPD Patients. Contrib Nephrol 1990; 85: 1–9.

Simmons R.L. , Ahrenholz D.H. Pathology of peritonitis: a review. J Antimicrob Chemother 1981; 7: S29–36.

Bos H.J. , Vlaanderen K. , Van der Meulen J. , De Veld J. , Oe L.P. , Beelen R.H.J. Peritoneal macrophages in short dwell time effluent show diminished phagocytosis. Perit Dial Int 1988; 8: 199–202.

Duwe A.K. , Vas S.I. , Weatherhead J.W. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis, and bactericidal activity in vitro. Infect Immun 1981; 33: 130–5.

Alobaidi H.M. , Coles G.A. , Dacies M. , Lloyd D. Host defence in continuous ambulatory peritoneal dialysis: the effect of the dialysate on phagocyte function. Nephrol Dial Transplant 1986; 1: 16–21.

De Fijter C.W.H. , Verbrugh H.A. , Peters E.D.J. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal dialysis patients. Clin Nephrol 1993; 39: 75–80.

De Fijter C.W.H. , Verbrugh H.A. , Oe P.L. The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1991; 7: 154–7.

De Fijter C.W.H. , Verbrugh H.A. , Oe P.L. Biocompatibility of a glucose-polymer containing peritoneal dialysis fluid. Am J Kidney Dis 1993; 21(4): 411–18.

McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B.J.R. Bactericidal activity of peritoneal macrophages from CAPD patients. Nephrol Dial Transplant 1987; 2: 104–8.

Lamperi S. , Carozzi S. Immunological defenses in CAPD. Blood Purif 1989; 7: 126–43.

Lin C.Y. , Ku W.L. , Huang T.P. Serial peritoneal macrophage function studies in new and established continuous ambulatory peritoneal dialysis patients. Am J Nephrol 1990; 10: 368–73.

Topley N. , Alobaidi H.M.M. , Davies M. , Coles G.A. , Williams J.D. , Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34: 404–11.

Lamperi S. , Carozzi S. Interferon-yas an in vitro enhancing factor of peritoneal macrophage defectivity of bacterial activity during continuous ambulatory peritoneal dialysis (CAPD). Am J Kidney Dis 1988; 11: 225–30.

Davies S.J. , Ogg CS , Cameron J.S. Peritoneal macrophage markers and phagocytic function in patients on CAPD. Nephrol Dial Transplant 1988; 3: 837–45.

Holmes C.J. , Lewis S.L. , Kubey W.J.Y. Comparison of peritoneal white blood cell parameters from CAPD patients with a high or low incidence of peritonitis. Am J Kidney Dis 1990; 15: 258–64.

McGregor S.J. , Brock J.H. , Briggs J.D. , Junor B.J.R. Bactericidal activity of peritoneal macrophages from CAPD patients. Nephrol Dial Transplant 1987; 2: 104–8.

Lewis S.L. , Kutvirt S.G. , Cooper C.L. , Bonner P.N. , Holmes C.J. Characteristics of peripheral and peritoneal lymphocytes from patients. Perit Dial Int 1993; 13: S273–7.

Zeillemaker A.M. , Hoynck van Papendrecht AAGM , Hart M.H.L. , Roos D. , Verbrugh H.A. , Leguit P. Peritoneal interleukin-8 in acute appendicitis. Ann Surg (in press).

Zemel D. , Krediet R.T. , Koomen G.C.M. , Kortekaas W.M.R. , Geertzen H.G.M. , Ten Berge I.J.M. Interleukin-8 during peritonitis in patients treated with CAPD; an in vivo model of acute inflammation. Nephrol Dial Transplant 1994; 9: 169–74.

Rapoport J. , Douvdevani A. , Conforti A. , Zlotnik M. , Chaimowitz C. Peritoneal mesothelial cells synthesize IL-l. J Am Soc Nephrol 1992; 3: 416.

Topley N. , Brown Z. , Jörres A. , Westwick J. , Davies M. , Coles G.A. , Williams J.D. Human peritoneal mesothelial cells synthesize IL-8; synergistic induction by IL-l and tumor necrosis factor α. Am J Pathol 1993; 142: 1–11.

Topley N. , Petersen M.M. , Mackenzie R. Human peritoneal mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by peritoneal macrophage derived cytokines. Kidney Int 1994; 46: 900–9.

Topley N. , Williams J.D. Role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 1994; 46(S48): S71–8.

Gordon D.L. , Rice J.L. , Avery V.M. Surface phagocytosis and host defense in the peritoneal cavity during continuous ambulatory peritoneal dialysis. Eur J Clin Microbiol Infect Dis 1990; 9: 191–7.

Haagen I.A. , Heezius HCJM , Verkooyen R.P. , Verhoeff J. , Verbrugh H.A. Adherence of peritonitis causing Staphylococci to human peritoneal mesothelial cell monolayers. J Infect Dis 1990; 161: 266–73.

Muijsken M.A. , de Fijter C.H.W. , Heezius E.C.J. , Oe P.L. , Verhoef J. , Verbrugh H.A. Intracellular survival of Staphylococci in both peritoneal macrophages and mesothelial cells as a possible cause of relapsing peritonitis. J Am Soc Nephrol 1991; 2: 366.

Zeillemaker A.M. , Mul F.P.J. , Hoynck van Papendrecht AAGM Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration. Immunology 1995 (in press).

Jonji N. , Peri G. , Bernasconi S. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992; 176: 1165–74.

Carozzi S. , Nasini M.G. Ca2+ concentration in the peritoneal dialysis solution regulates peritoneal fibroblast proliferation and peritoneal macrophage and lymphocyte cytokine release. Perit Dial Int 1993; 13(Suppl 2): S41–4.

Breborowicz A. , Patrikarea A. , Martis L. , Oreopoulos D.G. Effect of the dialysate effiuent from CAPD patients on peritoneal mesothelial cells and fibroblasts. In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1994; 10: 230–4.

Dobbie J.W. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Diallnt 1992; 12: 14–27.